Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01766882 · ClinicalTrials.gov registry record · NA
Volume,Sodium and Blood Pressure Management in HD
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01766882: Completed NA study, sponsored by University of Michigan.
NCT01766882 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01766882, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study to conduct a pilot, randomized trial in stable HD patients to evaluate the effect of gradual, step-wise reduction of post-hemodialysis target weight, combined with diligent dietary sodium restriction and reduction in dialysate sodium exposure on hydration/volume status and blood pressure (BP) control.
Primary Outcome
Change in blood pressure (pre-dialysis in-center blood pressure readings, ABPM and home BP monitoring)
Interventions
- BEHAVIORAL Lower sodium intervention
- OTHER Progressive Challenge to Post Dialysis Weight
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT01766882 record still lists
NCT01766882 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Lower sodium intervention is the first listed.
NCT01766882 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01766882 about?
NCT01766882 is a clinical study titled "Volume,Sodium and Blood Pressure Management in HD". The purpose of this study to conduct a pilot, randomized trial in stable HD patients to evaluate the effect of gradual, step-wise reduction of post-hemodialysis target weight, combined with diligent dietary sodium restriction and reduction in dialysate sodium exposure on hydration/volume status and ...
What is the current status of trial NCT01766882?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2012-09. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01766882?
The interventions under investigation include: Lower sodium intervention (BEHAVIORAL), Progressive Challenge to Post Dialysis Weight (OTHER).
Who is sponsoring clinical trial NCT01766882?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01766882's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia